Attenuation physics rule DE imaging
X-ray matter interactions in the diagnostic imaging energy range are dominated by photoelectric and Compton effects. Both interactions increase in proportion to electron density, which is proportional to physical density. In conventional CT imaging at 120 kVp to 140 kVp, the Compton effect predominates, and hence image quality is primarily governed by physical density.
X-ray matter interactions in the diagnostic imaging energy range are dominated by photoelectric and Compton effects. Both interactions increase in proportion to electron density, which is proportional to physical density. In conventional CT imaging at 120 kVp to 140 kVp, the Compton effect predominates, and hence image quality is primarily governed by physical density.
At lower kilovoltages, the frequency of Compton interactions remains relatively constant, whereas the frequency of photoelectric interactions increases exponentially. While the frequency of photoelectric interactions is strongly dependent on the atomic number Z (approximately proportional to Z3) the Compton effect is independent of the atomic number. For certain substances, the presence of elemental k-edges will further increase the frequency of photoelectric interactions at energies at, or just above, the k-edge (e.g., Iodine at 33keV).
Ultimately, attenuation displayed within a CT voxel is determined by the sum of different x-ray matter interactions, dominated by photoelectric and Compton interactions. Therefore, different substances will demonstrate different CT Hounsfield unit values at different energies. If the substances imaged have sufficiently distinct atomic numbers, it should, in principle, be possible to differentiate these substances based on their known attenuation properties at two different energies.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
